HEPA
PINK Hepion Pharmaceuticals, Inc.$0.1135 ↑ +0.0035 (+3.21%) Trading Up from the previous close of $0.1100, and at the day’s high of $0.1135
- YTD change
- +89.22%
- vs 20-day SMA
- +47.22%
- vs 200-day SMA
- +85.96%
Price ranges
Price & Performance
+0.06 (+100.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $8,350.0000
- HEPA is up 89% since the beginning of the year
- HEPA is up 127% over the past 12 months
- HEPA is up 20% over the past 1 month
- 0% of all HEPA investors are betting against HEPA
HEPA reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +120.0%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +43.71%
- vs 8-day SMA
- +39.26%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
